Literature DB >> 11030608

Changing concepts in the surgical management of acute pancreatitis.

B Gloor1, W Uhl, M W Büchler.   

Abstract

Most episodes of acute pancreatitis are mild and self-limiting, but severe disease complicated by multiple system organ failure develops in up to 20% of cases. Early detection of those patients who subsequently develop necrotizing pancreatitis allows the start of supportive treatment in the intensive care unit before organ failure occurs. Conservative treatment in the intensive care unit, including the administration of intravenous antibiotics, is the gold standard. Surgery is indicated in patients with infected pancreatic necrosis but not in patients with sterile necrosis in the absence of deteriorating multi-organ failure despite maximal intensive care unit treatment, or other specific surgical complications. At our institution, out of 44 patients with necrotizing pancreatitis 29 (66%) had sterile necrosis and were managed conservatively while 15 (34%) had infected pancreatic necrosis and were treated by necrosectomy and continuous closed retroperitoneal lavage. There were two deaths resulting in an overall mortality of 5% in patients with severe acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11030608     DOI: 10.1053/bega.1999.0026

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Gastroenterol


  3 in total

Review 1.  Acute pancreatitis at the beginning of the 21st century: the state of the art.

Authors:  Alfredo F Tonsi; Matilde Bacchion; Stefano Crippa; Giuseppe Malleo; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

2.  Audit of patients with severe acute pancreatitis admitted to an intensive care unit.

Authors:  Ratender Kumar Singh; Banani Poddar; Arvind Kumar Baronia; Afzal Azim; Mohan Gurjar; Sanjay Singhal; Shilpi Srivastava; Saurabh Saigal
Journal:  Indian J Gastroenterol       Date:  2012-08-30

3.  Acute necrotizing pancreatitis: treatment strategy according to the status of infection.

Authors:  M W Büchler; B Gloor; C A Müller; H Friess; C A Seiler; W Uhl
Journal:  Ann Surg       Date:  2000-11       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.